speb/financial-data huggingface dataset:
CLGN balance_sheet (annual, 2023-12-31) — Common Stock: 4982000.00
CLGN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 28340000.00
CLGN cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CLGN income_statement (annual, 2023-12-31) — Cost Of Revenue: 1991000.00
CLGN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 105000.00
CLGN balance_sheet (annual, 2023-12-31) — Current Assets: 28022000.00
CLGN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 624000.00
CLGN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 624000.00
CLGN balance_sheet (annual, 2023-12-31) — Current Liabilities: 3251000.00
CLGN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1102000.00
CLGN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1102000.00
CLGN income_statement (annual, 2023-12-31) — Diluted Average Shares: 11389168.00
CLGN income_statement (annual, 2023-12-31) — Diluted EPS: -0.62
CLGN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -7019000.00
CLGN income_statement (annual, 2023-12-31) — EBIT: -7512000.00
CLGN income_statement (annual, 2023-12-31) — EBITDA: -6410000.00
CLGN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -379000.00
CLGN cash_flow (annual, 2023-12-31) — End Cash Position: 26674000.00
CLGN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1108000.00
CLGN balance_sheet (annual, 2023-12-31) — Finished Goods: 541000.00
CLGN cash_flow (annual, 2023-12-31) — Free Cash Flow: -3717000.00
CLGN cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 18000.00
CLGN income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -285000.00
CLGN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 188000.00
CLGN balance_sheet (annual, 2023-12-31) — Gross PPE: 11905000.00
CLGN income_statement (annual, 2023-12-31) — Gross Profit: -163281.52
CLGN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 8000.00
CLGN income_statement (annual, 2023-12-31) — Interest Income: 788000.00
CLGN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 788000.00
CLGN balance_sheet (annual, 2023-12-31) — Inventory: 714000.00
CLGN balance_sheet (annual, 2023-12-31) — Invested Capital: 28340000.00
CLGN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1156000.00
CLGN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CLGN balance_sheet (annual, 2023-12-31) — Leases: 3503000.00
CLGN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2535000.00
CLGN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2535000.00
CLGN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 813000.00
CLGN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CLGN cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 379000.00
CLGN income_statement (annual, 2023-12-31) — Net Income: -7019000.00
CLGN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -7019000.00
CLGN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -7019000.00
CLGN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -7019000.00
CLGN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -7019000.00
CLGN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -7019000.00
CLGN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -7019000.00
CLGN cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
CLGN income_statement (annual, 2023-12-31) — Net Interest Income: 778000.00
CLGN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
CLGN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 778000.00
CLGN cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -270000.00
CLGN balance_sheet (annual, 2023-12-31) — Net PPE: 5859000.00
CLGN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -886000.00
CLGN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 28152000.00
CLGN income_statement (annual, 2023-12-31) — Normalized EBITDA: -6125000.00
CLGN income_statement (annual, 2023-12-31) — Normalized Income: -6734000.00
CLGN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -2763000.00
CLGN cash_flow (annual, 2023-12-31) — Operating Gains Losses: 397000.00
CLGN income_statement (annual, 2023-12-31) — Operating Income: -16643281.52
CLGN income_statement (annual, 2023-12-31) — Operating Revenue: 1827718.48
CLGN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 11452672.00
CLGN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -969000.00
CLGN income_statement (annual, 2023-12-31) — Other Income Expense: -285000.00
CLGN cash_flow (annual, 2023-12-31) — Other Non Cash Items: -28000.00
CLGN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 57000.00
CLGN balance_sheet (annual, 2023-12-31) — Other Payable: 105000.00
CLGN balance_sheet (annual, 2023-12-31) — Other Properties: 7589000.00
CLGN balance_sheet (annual, 2023-12-31) — Other Receivables: 393000.00
CLGN balance_sheet (annual, 2023-12-31) — Payables: 980000.00
CLGN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1085000.00
CLGN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1542000.00
CLGN income_statement (annual, 2023-12-31) — Pretax Income: -7019000.00
CLGN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1108000.00
CLGN balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLGN cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
CLGN cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
CLGN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -954000.00
CLGN balance_sheet (annual, 2023-12-31) — Receivables: 393000.00
CLGN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1991000.00
CLGN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1102000.00
CLGN income_statement (annual, 2023-12-31) — Research And Development: 10484000.00
CLGN balance_sheet (annual, 2023-12-31) — Restricted Cash: 241000.00
CLGN balance_sheet (annual, 2023-12-31) — Retained Earnings: -96741000.00
CLGN cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
CLGN cash_flow (annual, 2023-12-31) — Sale Of PPE: 68000.00
CLGN income_statement (annual, 2023-12-31) — Selling General And Administration: 5996000.00
CLGN balance_sheet (annual, 2023-12-31) — Share Issued: 11471081.00
CLGN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1937000.00
CLGN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 28340000.00
CLGN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 28152000.00
CLGN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CLGN balance_sheet (annual, 2023-12-31) — Total Assets: 34126000.00
CLGN balance_sheet (annual, 2023-12-31) — Total Capitalization: 28340000.00
CLGN balance_sheet (annual, 2023-12-31) — Total Debt: 3159000.00
CLGN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 28340000.00
CLGN income_statement (annual, 2023-12-31) — Total Expenses: 18471000.00
CLGN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 5786000.00
CLGN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 6104000.00
CLGN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2535000.00
CLGN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -7512000.00
CLGN income_statement (annual, 2023-12-31) — Total Other Finance Cost: 10000.00
CLGN income_statement (annual, 2023-12-31) — Total Unusual Items: -285000.00
CLGN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -285000.00
CLGN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 18409.00
CLGN balance_sheet (annual, 2023-12-31) — Work In Process: 173000.00
CLGN balance_sheet (annual, 2023-12-31) — Working Capital: 24771000.00
CLGN income_statement (quarterly, 2024-09-30) — Basic Average Shares: 11454512.00
CLGN income_statement (quarterly, 2024-09-30) — Basic EPS: -0.38
CLGN cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
CLGN balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 1262000.00
CLGN income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 11454512.00
CLGN income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.38
CLGN income_statement (quarterly, 2024-09-30) — Interest Income: 216000.00
CLGN income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 216000.00
CLGN cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
CLGN cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
CLGN cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 0.00
CLGN cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
CLGN income_statement (annual, 2024-12-31) — +Operating Expense: 16141000.00
CLGN income_statement (quarterly, 2024-12-31) — +Operating Expense: 3866000.00
CLGN income_statement (annual, 2024-12-31) — +Total Revenue: 515000.00
CLGN income_statement (quarterly, 2024-12-31) — +Total Revenue: 164000.00
CLGN balance_sheet (annual, 2024-12-31) — Accounts Payable: 870000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 870000.00
CLGN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 150000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 150000.00
CLGN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -7024000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -7024000.00
CLGN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 122801000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 122801000.00
CLGN income_statement (annual, 2024-12-31) — Basic Average Shares: 11454180.00
CLGN income_statement (annual, 2024-12-31) — Basic EPS: -1.45
CLGN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 26674000.00
CLGN cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 15371000.00
CLGN cash_flow (annual, 2024-12-31) — Capital Expenditure: -483000.00
CLGN cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -59000.00
CLGN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3081000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 3081000.00
CLGN balance_sheet (annual, 2024-12-31) — Capital Stock: 4983000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Capital Stock: 4983000.00
CLGN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 11909000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 11909000.00
CLGN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 11909000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 11909000.00
CLGN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 9000.00
CLGN cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CLGN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -539000.00
CLGN cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -58000.00
CLGN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -14093000.00
CLGN cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -3464000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Account Payable: -110000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -139000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -353000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: 32000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Inventory: 280000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Inventory: 15000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 651000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 183000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -650000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: -121000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Payable: -110000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Payable: -139000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -463000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -107000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Receivables: -190000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Receivables: -152000.00
CLGN cash_flow (annual, 2024-12-31) — Change In Working Capital: -372000.00
CLGN cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -182000.00
CLGN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -150000.00
CLGN cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -145000.00
CLGN cash_flow (annual, 2024-12-31) — Changes In Cash: -14623000.00
CLGN cash_flow (quarterly, 2024-12-31) — Changes In Cash: -3522000.00
CLGN balance_sheet (annual, 2024-12-31) — Common Stock: 4983000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Common Stock: 4983000.00
CLGN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 13465000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 13465000.00
CLGN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
CLGN income_statement (annual, 2024-12-31) — Cost Of Revenue: 1625000.00
CLGN income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 272000.00
CLGN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 101000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 101000.00
CLGN balance_sheet (annual, 2024-12-31) — Current Assets: 13180000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Current Assets: 13180000.00
CLGN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 806000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 806000.00
CLGN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 806000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 806000.00
CLGN balance_sheet (annual, 2024-12-31) — Current Liabilities: 2970000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 2970000.00
CLGN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1038000.00
CLGN cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 242000.00
CLGN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1038000.00
CLGN cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 242000.00
CLGN income_statement (annual, 2024-12-31) — Diluted Average Shares: 11454180.00
CLGN income_statement (annual, 2024-12-31) — Diluted EPS: -1.45
CLGN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -16609000.00
CLGN income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -3878000.00
CLGN income_statement (annual, 2024-12-31) — EBIT: -17251000.00
CLGN income_statement (quarterly, 2024-12-31) — EBIT: -3974000.00
CLGN income_statement (annual, 2024-12-31) — EBITDA: -16213000.00
CLGN income_statement (quarterly, 2024-12-31) — EBITDA: -3732000.00
CLGN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -142000.00
CLGN cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 60000.00
CLGN cash_flow (annual, 2024-12-31) — End Cash Position: 11909000.00
CLGN cash_flow (quarterly, 2024-12-31) — End Cash Position: 11909000.00
CLGN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 9000.00
CLGN cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 0.00
CLGN balance_sheet (annual, 2024-12-31) — Finished Goods: 154000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Finished Goods: 154000.00
CLGN cash_flow (annual, 2024-12-31) — Free Cash Flow: -14576000.00
CLGN cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -3523000.00
CLGN cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CLGN income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -79000.00
CLGN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 131000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 131000.00
CLGN balance_sheet (annual, 2024-12-31) — Gross PPE: 12305000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Gross PPE: 12305000.00
CLGN income_statement (annual, 2024-12-31) — Gross Profit: -1110000.00
CLGN income_statement (quarterly, 2024-12-31) — Gross Profit: -108000.00
CLGN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 62000.00
CLGN income_statement (annual, 2024-12-31) — Interest Income: 738000.00
CLGN income_statement (quarterly, 2024-12-31) — Interest Income: 192000.00
CLGN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 738000.00
CLGN income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 192000.00
CLGN balance_sheet (annual, 2024-12-31) — Inventory: 440000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Inventory: 440000.00
CLGN balance_sheet (annual, 2024-12-31) — Invested Capital: 13465000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Invested Capital: 13465000.00
CLGN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -539000.00
CLGN cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -58000.00
CLGN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
CLGN balance_sheet (annual, 2024-12-31) — Leases: 3650000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Leases: 3650000.00
CLGN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2275000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 2275000.00
CLGN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2275000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2275000.00
CLGN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 872000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 872000.00
CLGN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CLGN cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 142000.00
CLGN income_statement (annual, 2024-12-31) — Net Income: -16609000.00
CLGN income_statement (quarterly, 2024-12-31) — Net Income: -3878000.00
CLGN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -16609000.00
CLGN income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -3878000.00
CLGN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -16609000.00
CLGN income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -3878000.00
CLGN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -16609000.00
CLGN income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3878000.00
CLGN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -16609000.00
CLGN income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3878000.00
CLGN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -16609000.00
CLGN cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -3878000.00
CLGN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -16609000.00
CLGN income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -3878000.00
CLGN cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
CLGN income_statement (annual, 2024-12-31) — Net Interest Income: 721000.00
CLGN income_statement (quarterly, 2024-12-31) — Net Interest Income: 175000.00
CLGN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CLGN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 721000.00
CLGN income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 175000.00
CLGN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -57000.00
CLGN cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
CLGN balance_sheet (annual, 2024-12-31) — Net PPE: 5281000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Net PPE: 5281000.00
CLGN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -482000.00
CLGN cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -58000.00
CLGN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 13334000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 13334000.00
CLGN income_statement (annual, 2024-12-31) — Normalized EBITDA: -16134000.00
CLGN income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -3732000.00
CLGN income_statement (annual, 2024-12-31) — Normalized Income: -16530000.00
CLGN income_statement (quarterly, 2024-12-31) — Normalized Income: -3878000.00
CLGN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -14093000.00
CLGN cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -3464000.00
CLGN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 142000.00
CLGN income_statement (annual, 2024-12-31) — Operating Income: -17251000.00
CLGN income_statement (quarterly, 2024-12-31) — Operating Income: -3974000.00
CLGN income_statement (annual, 2024-12-31) — Operating Revenue: 515000.00
CLGN income_statement (quarterly, 2024-12-31) — Operating Revenue: 164000.00
CLGN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 11454512.00
CLGN balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 11454512.00
CLGN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -969000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -969000.00
CLGN income_statement (annual, 2024-12-31) — Other Income Expense: -79000.00
CLGN cash_flow (annual, 2024-12-31) — Other Non Cash Items: -11000.00
CLGN cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -212000.00
CLGN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 118000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 118000.00
CLGN balance_sheet (annual, 2024-12-31) — Other Payable: 101000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Other Payable: 101000.00
CLGN balance_sheet (annual, 2024-12-31) — Other Properties: 7783000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Other Properties: 7783000.00
CLGN balance_sheet (annual, 2024-12-31) — Other Receivables: 433000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Other Receivables: 433000.00
CLGN balance_sheet (annual, 2024-12-31) — Payables: 971000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Payables: 971000.00
CLGN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 971000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 971000.00
CLGN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1193000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1193000.00
CLGN income_statement (annual, 2024-12-31) — Pretax Income: -16609000.00
CLGN income_statement (quarterly, 2024-12-31) — Pretax Income: -3878000.00
CLGN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 9000.00
CLGN cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CLGN balance_sheet (annual, 2024-12-31) — Properties: 0.00
CLGN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CLGN cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
CLGN cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
CLGN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -483000.00
CLGN cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -59000.00
CLGN balance_sheet (annual, 2024-12-31) — Receivables: 583000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Receivables: 583000.00
CLGN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1625000.00
CLGN income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 272000.00
CLGN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1038000.00
CLGN income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 242000.00
CLGN income_statement (annual, 2024-12-31) — Research And Development: 10515000.00
CLGN income_statement (quarterly, 2024-12-31) — Research And Development: 2543000.00
CLGN balance_sheet (annual, 2024-12-31) — Restricted Cash: 248000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 248000.00
CLGN balance_sheet (annual, 2024-12-31) — Retained Earnings: -113350000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -113350000.00
CLGN cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
CLGN cash_flow (annual, 2024-12-31) — Sale Of PPE: 1000.00
CLGN income_statement (annual, 2024-12-31) — Selling General And Administration: 5626000.00
CLGN income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1323000.00
CLGN balance_sheet (annual, 2024-12-31) — Share Issued: 11472921.00
CLGN balance_sheet (quarterly, 2024-12-31) — Share Issued: 11472921.00
CLGN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1719000.00
CLGN cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 424000.00
CLGN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 13465000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 13465000.00
CLGN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 13334000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 13334000.00
CLGN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CLGN income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
CLGN balance_sheet (annual, 2024-12-31) — Total Assets: 18710000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Total Assets: 18710000.00
CLGN balance_sheet (annual, 2024-12-31) — Total Capitalization: 13465000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 13465000.00
CLGN balance_sheet (annual, 2024-12-31) — Total Debt: 3081000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Total Debt: 3081000.00
CLGN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 13465000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 13465000.00
CLGN income_statement (annual, 2024-12-31) — Total Expenses: 17766000.00
CLGN income_statement (quarterly, 2024-12-31) — Total Expenses: 4138000.00
CLGN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5245000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 5245000.00
CLGN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 5530000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 5530000.00
CLGN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2275000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2275000.00
CLGN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -17251000.00
CLGN income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -3974000.00
CLGN income_statement (annual, 2024-12-31) — Total Other Finance Cost: 17000.00
CLGN income_statement (annual, 2024-12-31) — Total Unusual Items: -79000.00
CLGN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -79000.00
CLGN balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 18409.00
CLGN balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 18409.00
CLGN balance_sheet (annual, 2024-12-31) — Work In Process: 286000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Work In Process: 286000.00
CLGN balance_sheet (annual, 2024-12-31) — Working Capital: 10210000.00
CLGN balance_sheet (quarterly, 2024-12-31) — Working Capital: 10210000.00
CLGN income_statement (quarterly, 2025-03-31) — +Operating Expense: 3515000.00
CLGN income_statement (quarterly, 2025-03-31) — +Total Revenue: 77000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 770000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 0.00
CLGN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 123185000.00
CLGN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 11454512.00
CLGN income_statement (quarterly, 2025-03-31) — Basic EPS: -0.13
CLGN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 11909000.00
CLGN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -9000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2843000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4983000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 10735000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10735000.00
CLGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
CLGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -8000.00
CLGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1167000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -100000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -96000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Inventory: -231000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 165000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -225000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Payable: -100000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -196000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 143000.00
CLGN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -344000.00
CLGN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 150000.00
CLGN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1175000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Common Stock: 4983000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 12397000.00
CLGN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 188000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1198000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Current Assets: 12093000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 732000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 732000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2700000.00
CLGN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 244000.00
CLGN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 244000.00
CLGN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 11454512.00
CLGN income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.13
CLGN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1452000.00
CLGN income_statement (quarterly, 2025-03-31) — EBIT: -1648000.00
CLGN income_statement (quarterly, 2025-03-31) — EBITDA: -1404000.00
CLGN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1000.00
CLGN cash_flow (quarterly, 2025-03-31) — End Cash Position: 10735000.00
CLGN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
CLGN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1176000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 116000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4882000.00
CLGN income_statement (quarterly, 2025-03-31) — Gross Profit: -111000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Inventory: 673000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 12397000.00
CLGN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -8000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2111000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2111000.00
CLGN cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 6000.00
CLGN income_statement (quarterly, 2025-03-31) — Net Income: -1452000.00
CLGN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1452000.00
CLGN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1452000.00
CLGN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1452000.00
CLGN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1452000.00
CLGN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1452000.00
CLGN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1452000.00
CLGN income_statement (quarterly, 2025-03-31) — Net Interest Income: 196000.00
CLGN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 196000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Net PPE: 4882000.00
CLGN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -8000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 12281000.00
CLGN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1404000.00
CLGN income_statement (quarterly, 2025-03-31) — Normalized Income: -1452000.00
CLGN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1167000.00
CLGN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 6000.00
CLGN income_statement (quarterly, 2025-03-31) — Operating Income: -3626000.00
CLGN income_statement (quarterly, 2025-03-31) — Operating Revenue: 77000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 11454512.00
CLGN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -969000.00
CLGN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -3000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 117000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Other Properties: 4882000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 440000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Payables: 770000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1968000.00
CLGN income_statement (quarterly, 2025-03-31) — Pretax Income: -1452000.00
CLGN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CLGN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -9000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Receivables: 440000.00
CLGN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 188000.00
CLGN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 244000.00
CLGN income_statement (quarterly, 2025-03-31) — Research And Development: 2105000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 245000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -114802000.00
CLGN cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 1000.00
CLGN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1410000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Share Issued: 11472921.00
CLGN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 382000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 12397000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 12281000.00
CLGN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CLGN balance_sheet (quarterly, 2025-03-31) — Total Assets: 17208000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 12397000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Total Debt: 2843000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 12397000.00
CLGN income_statement (quarterly, 2025-03-31) — Total Expenses: 3703000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4811000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5115000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2111000.00
CLGN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1648000.00
CLGN income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -196000.00
CLGN balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 18409.00
CLGN balance_sheet (quarterly, 2025-03-31) — Working Capital: 9393000.00
CLGN income_statement (quarterly, 2025-06-30) — +Operating Expense: 3171000.00
CLGN income_statement (quarterly, 2025-06-30) — +Total Revenue: 179000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 571000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 0.00
CLGN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 126131000.00
CLGN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 11840829.00
CLGN income_statement (quarterly, 2025-06-30) — Basic EPS: -0.28
CLGN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 10735000.00
CLGN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 3027000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 5492000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 11434000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 11434000.00
CLGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 3102000.00
CLGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3000.00
CLGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2440000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -199000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 136000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Inventory: 120000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 160000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 113000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Payable: -199000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -63000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Receivables: 76000.00
CLGN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 406000.00
CLGN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 0.00
CLGN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 659000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Common Stock: 5492000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 12505000.00
CLGN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 186000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1334000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Current Assets: 12624000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 837000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 837000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2742000.00
CLGN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 229000.00
CLGN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 229000.00
CLGN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 11840829.00
CLGN income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.28
CLGN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -3347000.00
CLGN income_statement (quarterly, 2025-06-30) — EBIT: -3178000.00
CLGN income_statement (quarterly, 2025-06-30) — EBITDA: -2949000.00
CLGN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 40000.00
CLGN cash_flow (quarterly, 2025-06-30) — End Cash Position: 11434000.00
CLGN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 3102000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Finished Goods: 494000.00
CLGN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2443000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -969000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 102000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4581000.00
CLGN income_statement (quarterly, 2025-06-30) — Gross Profit: -7000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Inventory: 553000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 12505000.00
CLGN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2190000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2190000.00
CLGN cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -77000.00
CLGN income_statement (quarterly, 2025-06-30) — Net Income: -3347000.00
CLGN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -3347000.00
CLGN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3347000.00
CLGN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3347000.00
CLGN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3347000.00
CLGN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -3347000.00
CLGN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -3347000.00
CLGN income_statement (quarterly, 2025-06-30) — Net Interest Income: -169000.00
CLGN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -169000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Net PPE: 4581000.00
CLGN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 12403000.00
CLGN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2949000.00
CLGN income_statement (quarterly, 2025-06-30) — Normalized Income: -3347000.00
CLGN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2440000.00
CLGN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -77000.00
CLGN income_statement (quarterly, 2025-06-30) — Operating Income: -3178000.00
CLGN income_statement (quarterly, 2025-06-30) — Operating Revenue: 179000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 12716014.00
CLGN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -969000.00
CLGN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -4000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 130000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Other Properties: 4581000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 364000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Payables: 571000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1905000.00
CLGN income_statement (quarterly, 2025-06-30) — Pretax Income: -3347000.00
CLGN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
CLGN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Receivables: 364000.00
CLGN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 186000.00
CLGN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 229000.00
CLGN income_statement (quarterly, 2025-06-30) — Research And Development: 2013000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 273000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -118149000.00
CLGN cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
CLGN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1158000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Share Issued: 12734423.00
CLGN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 353000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 12505000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 12403000.00
CLGN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CLGN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CLGN balance_sheet (quarterly, 2025-06-30) — Total Assets: 17437000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 12505000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Total Debt: 3027000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 12505000.00
CLGN income_statement (quarterly, 2025-06-30) — Total Expenses: 3357000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4932000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4813000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2190000.00
CLGN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3178000.00
CLGN income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 169000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 18409.00
CLGN balance_sheet (quarterly, 2025-06-30) — Work In Process: 59000.00
CLGN balance_sheet (quarterly, 2025-06-30) — Working Capital: 9882000.00
CLGN income_statement (quarterly, 2025-09-30) — +Operating Expense: 3315000.00
CLGN income_statement (quarterly, 2025-09-30) — +Total Revenue: 77000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 618000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 11000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 126414000.00
CLGN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 12722203.00
CLGN income_statement (quarterly, 2025-09-30) — Basic EPS: -0.27
CLGN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 11434000.00
CLGN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2940000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 5492000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 8547000.00
CLGN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8547000.00
CLGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
CLGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1000.00
CLGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2877000.00
CLGN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 47000.00
CLGN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -108000.00
CLGN cash_flow (quarterly, 2025-09-30) — Change In Inventory: 14000.00
CLGN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 171000.00
CLGN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -130000.00
CLGN cash_flow (quarterly, 2025-09-30) — Change In Payable: 47000.00